Weizao Chen

2.7k total citations
59 papers, 2.1k citations indexed

About

Weizao Chen is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Virology. According to data from OpenAlex, Weizao Chen has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Radiology, Nuclear Medicine and Imaging, 30 papers in Molecular Biology and 25 papers in Virology. Recurrent topics in Weizao Chen's work include Monoclonal and Polyclonal Antibodies Research (39 papers), HIV Research and Treatment (25 papers) and Glycosylation and Glycoproteins Research (18 papers). Weizao Chen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (39 papers), HIV Research and Treatment (25 papers) and Glycosylation and Glycoproteins Research (18 papers). Weizao Chen collaborates with scholars based in United States, China and United Kingdom. Weizao Chen's co-authors include Dimiter S. Dimitrov, Yang Feng, Zhongyu Zhu, Ponraj Prabakaran, Xiaodong Xiao, Tianlei Ying, Rui Gong, Mingqiu Liu, Weiyao Yan and Zhaoxin Zheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Weizao Chen

59 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weizao Chen United States 26 1.0k 840 734 600 329 59 2.1k
Yang Feng United States 28 1.0k 1.0× 989 1.2× 702 1.0× 498 0.8× 377 1.1× 58 2.5k
Wilfred E. Marissen United States 22 997 1.0× 284 0.3× 447 0.6× 435 0.7× 181 0.6× 27 2.3k
Mikkel Harndahl Denmark 21 1.7k 1.7× 626 0.7× 1.7k 2.4× 288 0.5× 439 1.3× 40 2.6k
Theo Verrips Netherlands 28 1.1k 1.1× 1.1k 1.3× 536 0.7× 271 0.5× 160 0.5× 47 1.9k
Bernard Krust France 31 1.7k 1.7× 196 0.2× 983 1.3× 1.2k 2.0× 467 1.4× 66 3.3k
Miriam Siekevitz United States 16 741 0.7× 533 0.6× 1.9k 2.5× 435 0.7× 211 0.6× 22 2.6k
Jonathan Rothbard United Kingdom 11 816 0.8× 341 0.4× 1.2k 1.6× 669 1.1× 206 0.6× 13 2.1k
Oleksandr Kalyuzhniy United States 17 1.3k 1.3× 596 0.7× 837 1.1× 824 1.4× 251 0.8× 26 2.4k
Anette Stryhn Denmark 25 1.3k 1.3× 522 0.6× 1.4k 1.8× 220 0.4× 630 1.9× 61 2.8k
Richard J. Gulizia United States 17 548 0.5× 323 0.4× 1.3k 1.8× 1.0k 1.7× 418 1.3× 22 2.5k

Countries citing papers authored by Weizao Chen

Since Specialization
Citations

This map shows the geographic impact of Weizao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizao Chen more than expected).

Fields of papers citing papers by Weizao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weizao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizao Chen. The network helps show where Weizao Chen may publish in the future.

Co-authorship network of co-authors of Weizao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Weizao Chen. A scholar is included among the top collaborators of Weizao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weizao Chen. Weizao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jie, Yaming Shan, Guixing Ma, et al.. (2018). A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells. International Journal of Biological Sciences. 14(7). 799–806. 8 indexed citations
2.
Boliar, Saikat, Weizao Chen, Javier Guenaga, et al.. (2018). Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category. Virology. 519. 99–105. 4 indexed citations
3.
Schneider, Dina, Ying Xiong, Peirong Hu, et al.. (2018). A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid Leukemia. Frontiers in Oncology. 8. 539–539. 32 indexed citations
4.
Ying, Tianlei, Yang Feng, Yanping Wang, Weizao Chen, & Dimiter S. Dimitrov. (2014). Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseases. mAbs. 6(5). 1201–1210. 22 indexed citations
5.
Chen, Weizao, Yang Feng, Ponraj Prabakaran, et al.. (2013). Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains. Journal of Virology. 88(2). 1125–1139. 54 indexed citations
6.
Tang, Zhewei, Mingqian Feng, Wei Gao, et al.. (2013). A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface. Molecular Cancer Therapeutics. 12(4). 416–426. 38 indexed citations
7.
Chen, Weizao, Tianlei Ying, & Dimiter S. Dimitrov. (2013). Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design. Expert Opinion on Biological Therapy. 13(5). 657–671. 20 indexed citations
8.
Chen, Weizao, Yang Feng, Qi Zhao, Zhongyu Zhu, & Dimiter S. Dimitrov. (2012). Human Monoclonal Antibodies Targeting Nonoverlapping Epitopes on Insulin-like Growth Factor II as a Novel Type of Candidate Cancer Therapeutics. Molecular Cancer Therapeutics. 11(7). 1400–1410. 26 indexed citations
9.
Prabakaran, Ponraj, Zhongyu Zhu, Weizao Chen, et al.. (2012). Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing. Frontiers in Microbiology. 3. 277–277. 24 indexed citations
10.
Gong, Rui, Weizao Chen, & Dimiter S. Dimitrov. (2012). Expression, Purification, and Characterization of Engineered Antibody CH2 and VH Domains. Methods in molecular biology. 899. 85–102. 11 indexed citations
11.
Gong, Rui, Weizao Chen, & Dimiter S. Dimitrov. (2012). Candidate Antibody-Based Therapeutics Against HIV-1. BioDrugs. 26(3). 143–162. 13 indexed citations
12.
13.
Chen, Weizao, Xiaodong Xiao, Yanping Wang, Zhongyu Zhu, & Dimiter S. Dimitrov. (2010). Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates. Antiviral Research. 88(1). 107–115. 34 indexed citations
14.
Chen, Weizao, Zhongyu Zhu, Yang Feng, & Dimiter S. Dimitrov. (2009). A large human domain antibody library combining heavy and light chain CDR3 diversity. Molecular Immunology. 47(4). 912–921. 16 indexed citations
15.
Chen, Weizao & Dimiter S. Dimitrov. (2009). Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors. Current Opinion in HIV and AIDS. 4(2). 112–117. 30 indexed citations
16.
Chen, Weizao, Zhongyu Zhu, Yang Feng, Xiaodong Xiao, & Dimiter S. Dimitrov. (2008). Construction of a Large Phage-Displayed Human Antibody Domain Library with a Scaffold Based On a Newly Identified Highly Soluble, Stable Heavy Chain Variable Domain. Journal of Molecular Biology. 382(3). 779–789. 56 indexed citations
17.
Cheng, Gong, Xin Zhao, Weizao Chen, et al.. (2007). Detection of Differential Expression of Porcine IFN- α Subtypes by Reverse Transcription Polymerase Chain Reaction. Journal of Interferon & Cytokine Research. 27(7). 579–588. 8 indexed citations
18.
Liu, Mingqiu, Weizao Chen, Zheng Ni, et al.. (2005). Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome. Virology. 336(1). 51–59. 45 indexed citations
19.
Chen, Weizao, Mingqiu Liu, Gong Cheng, et al.. (2005). RNA silencing: A remarkable parallel to protein‐based immune systems in vertebrates?. FEBS Letters. 579(11). 2267–2272. 6 indexed citations
20.
Chen, Weizao, Weiyao Yan, Fei Liang, et al.. (2004). RNA Interference Targeting VP1 Inhibits Foot-and-Mouth Disease Virus Replication in BHK-21 Cells and Suckling Mice. Journal of Virology. 78(13). 6900–6907. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Feng Breakdown of academic impact, for papers by Wilfred E. Marissen Breakdown of academic impact, for papers by Mikkel Harndahl Breakdown of academic impact, for papers by Theo Verrips Breakdown of academic impact, for papers by Bernard Krust Breakdown of academic impact, for papers by Miriam Siekevitz Breakdown of academic impact, for papers by Jonathan Rothbard Breakdown of academic impact, for papers by Oleksandr Kalyuzhniy Breakdown of academic impact, for papers by Anette Stryhn Breakdown of academic impact, for papers by Richard J. Gulizia
Rankless by CCL
2026